F.D.A. Finds Safety Problems At Company Supplying Drugs.

The article reports on the inspection of unsafe practices and unsanitary conditions at Ameridose by the U.S. Food and Drug Administration (FDA). FDA spokeswoman Sarah Clark-Lynn, says that the company could not assure that their injectable products were safe and sterile for use by patients. It mentions that the company committed to address safety problems at the company to enhance the existing systems.